Genetics Home
Our Department    Faculty/Labs    Graduate Program    Medical Genetics    Directory   


Back to Main Faculty Page
Visit Tian Xu's Laboratory

Tian Xu
Tian Xu
Professor of Genetics, Molecular Oncology and Development,
Vice Chairman of Genetics
Investigator of the Howard Hughes Medical Institute
* B.S. Fudan University, Shanghai, 1982
* Ph.D. Yale University, 1990
Research Interests:
* Genetic Basis of Metastatic Behavior
* Size-control Mechanisms in Development & Tumorigenesis
* Pioneering New Genetic Methodologies
* Deciphering Mammalian Biology and Disease by Large-Scale Transposon Mutagenesis in Mice
Honors:
* Helen H. Whitney Fellow
* Pew Scholar Award
* Tuberous Sclerosis Alliance Rothberg Courage Award
The Xu lab is is interested in utilizing model organisms to understand cancer biology and developmental mechanisms. In particular, the lab is developing and using new genetic approaches to identify genes that are involved in tumor growth and metastasis, and are exploring the developmental and biochemical functions of these genes.
Current Research:
Metastasis is the major cause of mortality for cancer patients. Given that alterations causing metastasis are late events and that multiple genetic alterations occur in late stage cancers, traditional approaches have not been fruitful in identifying genes involved in metastasis. We have performed a genome-wide genetic screen for mutations promoting tumor progression and metastasis in Drosophila and have identified mutations in more than 50 genes. We have found that apicobasal polarity mutations in collaboration with oncogenic Ras mutation produce fly tumors with a full spectrum of metastatic phenotypes observed in human malignant cancers. Mutation of cell polarity genes activates JNK signaling and down-regulates the E-cadherin/b-catenin adhesion complex. Furthermore, JNK and Ras signaling cooperate in promoting tumor growth. The concept that tumor-initiating alterations contribute to the development of metastasis, provides an explanation why tumors of distinguish origins have vast different metastatic potential. Our work has also revealed that tumor cells hijack normal invasive developmental process to achieve progression. Elements of the invasion machinery, including JNK-induced MMP expression, are shared by both developmental and tumor invasion processes. Preventing BM degradation completely blocks both tissue and tumor invasion, indicating that modulation of BM is essential for invasion. The pathways regulate invasion during development and tumor progression are excellent targets for cancer therapy.
Our work on tumor growth have shown that tumor suppressors such as TSC, PTEN, and LATS regulate tissue and organism size during development and propose that deregulation of size-control mechanisms is essential for tumorigenesis. We have showed that TSC and PTEN genes function in the PI3K/Akt pathway and reduction of S6K activity levitates TSC defects. These findings have helped to define one of the major cancer pathways in humans and have lead to clinical trials for TSC and LAM diseases.
One of our long term goal is to develop methodologies in mammals for interrogating the genome by forward genetics. We have successfully adapted the piggyBac transposon for transgenesis and insertional mutagenesis in mammals. This has led to the development of a highly efficient single transposon mutagenesis strategy and to the near-production of the first set of genome-wide insertional mutants in mice, which will provide an unprecedented opportunity for deciphering mammalian biology and disease.
Representative Publications:
Potter, C.J., Huang, H., and Xu, T. (2001). Drosophila Tsc1 functions with Tsc2 to antagonize insulin signaling in
regulating cell growth, cell proliferation, and organ size. Cell 105: 357-368.
Potter, C.J., Pedraza, L.G. and Xu, T. (2002). Akt regulates growth by directly phosphorylating Tsc2. Nature Cell Biology, 4: 658-665.
Raymond A. Pagliarini and Tian Xu (2003). A Genetic Screen in Drosophila for Metastatic Behavior. Science 14:1227-31.
Ding, S., Wu, X., Li, G., Han, M., Zhuang, Y., and Xu, T. (2005). EfficientTransposition of the piggyBac (PB) Transposon in Mammalian Cells and Mice. Cell 122:473-483.
Igaki, T., Pagliarini, R.A. and Xu, T. (2006). Loss of cell polarity drives tumor growth and invasion through JNK activation in Drosophila. Curr. Biol. 16:1139-1146.
Xue, L., Igaki, T., Kuranaga, E., Kanda, H., Miura, M. and Xu, T. (2007). Tumor Suppressor CYLD Regulates JNK Induced Cell Death in Drosophila. Dev. Cell 3:446-454.
Ding, S., Wu, X., Li, G., Han, M., Zhuang, Y., and Xu, T. (2005). Efficient Transposition of the piggyBac (PB) Transposon in Mammalian Cells and Mice. Cell 122:473-483.
Contact Information:
tian.xu@yale.edu
Tian Xu's Lab page
YALE

YSMinfo   Library    Calendar   New Haven   Contact Us   

Connecticut Virtual Tours by MTHarris Computer Associates and Connecticut Creative Website Design by MTHarris Computer Associates at wwww.mtharris.com